Search Legislation

The Veterinary Medicines and Animals and Animal Products (Examination of Residues and Maximum Residue Limits) (Amendment etc.) (EU Exit) Regulations 2019

 Help about what version

What Version

 Help about advanced features

Advanced Features

 Help about opening options

Opening Options

Changes over time for: PART 4

 Help about opening options

Alternative versions:

Changes to legislation:

There are currently no known outstanding effects for the The Veterinary Medicines and Animals and Animal Products (Examination of Residues and Maximum Residue Limits) (Amendment etc.) (EU Exit) Regulations 2019, PART 4. Help about Changes to Legislation

Close

Changes to Legislation

Revised legislation carried on this site may not be fully up to date. At the current time any known changes or effects made by subsequent legislation have been applied to the text of the legislation you are viewing by the editorial team. Please see ‘Frequently Asked Questions’ for details regarding the timescales for which new effects are identified and recorded on this site.

PART 4U.K.Amendment and revocation of retained direct EU legislation

Regulation (EC) No 726/2004 of the European Parliament and of the CouncilU.K.

5.  Regulation (EC) No 726/2004 of the European Parliament and of the Council laying down Community procedures for the authorisation and supervision of medicinal products for human and veterinary use and establishing a European Medicines Agency is revoked insofar as it applies to medicinal products for veterinary use.

Commencement Information

I1Reg. 5 in force at 31.12.2020 on IP completion day (in accordance with 2020 c. 1, Sch. 5 para. 1(1)), see reg. 1(2)(b)

Regulation (EC) 470/2009 of the European Parliament and of the CouncilU.K.

6.—(1) Regulation (EC) 470/2009 of the European Parliament and of the Council laying down Community procedures for the establishment of residue limits of pharmacologically active substances in foodstuffs of animal origin is amended as follows.

(2) In Article 1(3)—

(a)omit “Community”;

(b)after “for by” insert “ the retained EU law which transposed ”.

F1(3) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

(4) In Article 3—

(a)for the heading substitute “ Scope ”;

(b)for the first paragraph substitute—

This Regulation applies to any pharmacologically active substance intended for use in [F2Great Britain] in veterinary medicinal products which are to be administered to food producing animals.;

(c)omit the second paragraph.

(5) In Article 4—

(a)for the heading substitute “ Assessment report ”;

(b)for paragraph 1 substitute—

1.  Where an application for a new or amended maximum residue limit for a substance intended for use in a veterinary medicinal product is made under Article 8, the [F3Secretary of State] must produce an assessment report which includes a scientific risk assessment and risk management recommendations for the purposes of establishing maximum residue limits for the substance in question.;

(c)in paragraph 2, for the second sentence substitute—

The assessment report must take account of any relevant findings of internationally recognised scientific bodies.;

F4(d). . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

(6) In Article 5, for the words from “, the Agency” to the end substitute—

whilst ensuring a high level of protection of human health, the [F5Secretary of State] must consider extrapolating maximum residue limits from one species to another or from one foodstuff to another when drafting risk management recommendations.

(7) In Article 6(1), omit the words from “expressed in terms” to the end.

(8) For Article 11 substitute—

Article 11U.K.Review of maximum residue limit

Where the [F6Secretary of State] considers that a review of the maximum residue limit for a substance is necessary in order to protect human or public health and issues a notice to that effect to the Veterinary Products Committee, that Committee must review the substance in question and report its findings to the [F6Secretary of State] , together with any recommendations..

(9) In Article 12, for the words from “Agency” to “11” substitute [F7Secretary of State] must publish the assessment report referred to in Article 4 ”.

(10) Omit Article 13.

(11) Omit Article 15.

(12) In Article 16—

(a)in paragraph 1, omit the words from “within the” to the end;

(b)for paragraph 2 substitute—

2.  Paragraph 1 does not apply in the case of clinical trials which are authorised under an Animal Test Certificate..

(13) Omit Article 17.

(14) In Article 18—

(a)in the first paragraph, for “Commission” substitute [F8Secretary of State];

(b)in the second paragraph, for “Article 24” substitute “ relevant international decisions ”;

(c)omit the third paragraph.

(15) In Article 19—

(a)for paragraph 1 substitute—

The reference point for action must be set having taken into account the lowest residue concentration which can be quantified with an analytical method validated in accordance with the Annex to Commission Decision 2002/657/EC. The relevant national reference laboratory must advise the appropriate authority on the performance of analytical methods.;

(b)omit paragraphs 2 and 3.

(16) Omit Article 20.

(17) For Article 21 substitute—

Article 21U.K.Analytical methods

The [F9Secretary of State] must consult relevant national reference laboratories on appropriate analytical methods for detecting residues of pharmacologically active substances for which maximum residue limits have been determined in accordance with Article 14..

(18) Omit Article 22.

(19) In Article 23—

(a)in the first paragraph, in the words after point (b), for “Community legislation” substitute “ retained EU law ”;

(b)omit the second paragraph.

(20) Omit Articles 24 to 28.

(21) In Article 29, omit the first two paragraphs.

(22) Omit Articles 30 to 32.

(23) After Article 32, omit the words from “This Regulation” to “Member States”.

Textual Amendments

F1Reg. 6(3) omitted (31.12.2020 immediately before IP completion day) by virtue of The Veterinary Medicines and Residues (Amendment) (EU Exit) Regulations 2020 (S.I. 2020/1461), regs. 1(2)(a), 3(4)(a)

F2Words in reg. 6(4)(b) substituted (31.12.2020 immediately before IP completion day) by The Veterinary Medicines and Residues (Amendment) (EU Exit) Regulations 2020 (S.I. 2020/1461), regs. 1(2)(a), 3(4)(b)

F3Words in reg. 6(5)(b) substituted (31.12.2020 immediately before IP completion day) by The Veterinary Medicines and Residues (Amendment) (EU Exit) Regulations 2020 (S.I. 2020/1461), regs. 1(2)(a), 3(4)(c)(i)

F4Reg. 6(5)(d) omitted (31.12.2020 immediately before IP completion day) by virtue of The Veterinary Medicines and Residues (Amendment) (EU Exit) Regulations 2020 (S.I. 2020/1461), regs. 1(2)(a), 3(4)(c)(ii)

F5Words in reg. 6(6) substituted (31.12.2020 immediately before IP completion day) by The Veterinary Medicines and Residues (Amendment) (EU Exit) Regulations 2020 (S.I. 2020/1461), regs. 1(2)(a), 3(4)(d)

F6Words in reg. 6(8) substituted (31.12.2020 immediately before IP completion day) by The Veterinary Medicines and Residues (Amendment) (EU Exit) Regulations 2020 (S.I. 2020/1461), regs. 1(2)(a), 3(4)(e)

F7Words in reg. 6(9) substituted (31.12.2020 immediately before IP completion day) by The Veterinary Medicines and Residues (Amendment) (EU Exit) Regulations 2020 (S.I. 2020/1461), regs. 1(2)(a), 3(4)(f)

F8Words in reg. 6(14)(a) substituted (31.12.2020 immediately before IP completion day) by The Veterinary Medicines and Residues (Amendment) (EU Exit) Regulations 2020 (S.I. 2020/1461), regs. 1(2)(a), 3(4)(g)

F9Words in reg. 6(17) substituted (31.12.2020 immediately before IP completion day) by The Veterinary Medicines and Residues (Amendment) (EU Exit) Regulations 2020 (S.I. 2020/1461), regs. 1(2)(a), 3(4)(h)

Commencement Information

I2Reg. 6 in force at 31.12.2020 on IP completion day (in accordance with 2020 c. 1, Sch. 5 para. 1(1)), see reg. 1(2)(b)

Commission Regulation (EU) No 37/2010U.K.

7.  Commission Regulation (EU) No 37/2010 on pharmacologically active substances and their classification regarding maximum residue limits in foodstuffs of animal origin is revoked.

Commencement Information

I3Reg. 7 in force at 31.12.2020 on IP completion day (in accordance with 2020 c. 1, Sch. 5 para. 1(1)), see reg. 1(2)(b)

Commission Implementing Regulation (EU) 2017/12U.K.

8.—(1) Commission Implementing Regulation (EU) 2017/12 regarding the form and content of the applications and requests for the establishment of maximum residue limits in accordance with Regulation (EC) No 470/2009 of the European Parliament and of the Council is amended as follows.

(2) In Article 1—

(a)in paragraph 1, for “European Medicines Agency (EMA)” substitute “ the appropriate authority ”;

(b)after paragraph 2 insert—

3.  In this Regulation, “appropriate authority” is to be read in accordance with Article 2(4) and (5)..

(3) In Article 2—

(a)in paragraph 1, for “EMA” substitute “ the appropriate authority ”;

(b)in paragraph 3, for “EMA” substitute “ The appropriate authority ”;

(c)after paragraph 3 insert—

4.  In paragraph 1, “appropriate authority” means—

(a)in relation to England, Wales and Scotland, the Secretary of State;

(b)in relation to Northern Ireland, the Department of Agriculture, Environment and Rural Affairs.

5.  But the appropriate authority is the Secretary of State if consent is given in relation to Northern Ireland by the Department of Agriculture, Environment and Rural Affairs..

(4) After Article 3, omit the words from “This Regulation” to “Member States”.

(5) In the Annex—

(a)in paragraph 2, for “EMA” substitute “ appropriate authority ”:

(b)in paragraph B.3.2 of Chapter 2, for “Commission and the EMA” substitute “ appropriate authority ”.

Commencement Information

I4Reg. 8 in force at 31.12.2020 on IP completion day (in accordance with 2020 c. 1, Sch. 5 para. 1(1)), see reg. 1(2)(b)

Commission Regulation (EU) 2017/880U.K.

9.—(1) Commission Regulation (EU) 2017/880 laying down rules on the use of a maximum residue limit established for a pharmacologically active substance in a particular foodstuff for another foodstuff derived from the same species and a maximum residue limit established for a pharmacologically active substance in one or more species for other species, in accordance with Regulation (EC) No 470/2009 of the European Parliament and of the Council is amended as follows.

(2) In Article 2, after paragraph (6) insert—

(7) ‘appropriate authority’ is to be read in accordance with Article 3(2) and (3)..

(3) In Article 3—

(a)renumber the existing text as paragraph 1;

(b)in that paragraph, for “EMA” substitute “ appropriate authority ”;

(c)after that paragraph insert—

2.  In paragraph 1, “appropriate authority” means—

(a)in relation to England, Wales and Scotland, the Secretary of State;

(b)in relation to Northern Ireland, the Department of Agriculture, Environment and Rural Affairs.

3.  But the appropriate authority is the Secretary of State if consent is given in relation to Northern Ireland by the Department of Agriculture, Environment and Rural Affairs..

(4) In Articles 4 to 7 for “EMA”, in each place it occurs, substitute “ appropriate authority ”.

(5) After Article 8, omit the words from “This Regulation” to “Member States”.

Commencement Information

I5Reg. 9 in force at 31.12.2020 on IP completion day (in accordance with 2020 c. 1, Sch. 5 para. 1(1)), see reg. 1(2)(b)

Commission Regulation (EU) 2018/782U.K.

10.—(1) Commission Regulation (EU) 2018/782 establishing the methodological principles for the risk assessment and risk management recommendations referred to in Regulation (EC) No 470/2009 is amended as follows.

(2) In Article 1—

(a)for “Agency” substitute “ appropriate authority ”;

(b)for “preparing opinions on the” substitute “ producing an assessment report in respect of ”.

(3) After Article 3, omit the words from “This Regulation” to “Member States”.

(4) In Annex 1—

(a)in paragraph 1.1, for the words from “provisions related” to “Council” substitute “ the Good Laboratory Practice Regulations 1999 M1;

(b)in paragraph 1.2, for “Directive 2010/63/EU of the European Parliament and of the Council” substitute “ the Animals (Scientific Procedures) Act 1986 M2;

(c)in paragraph 1.7, in the second subparagraph—

(i)for “European Medicines Agency (‘Agency’)” substitute “ appropriate authority ”;

(ii)for “the Agency” substitute “ the appropriate authority ”;

(d)in paragraph 1.8, for the words from “the Agency's” to the end substitute “ guidance issued by the appropriate authority ”;

(e)in paragraph 2.4.2(l), omit “Agency and other”;

(f)in paragraph 2.4.2(m), for “Directive 2010/63/EU” substitute “ the Animals (Scientific Procedures) Act 1986 ”;

(g)in paragraph 2.6.1.3, for “Agency” substitute “ appropriate authority ”;

(h)in paragraph 3.2.2(j), omit “Agency and other”;

(i)in paragraph 3.2.2(k), for “Directive 2010/63/EU” substitute “ the Animals (Scientific Procedures) Act 1986 ”;

(j)in paragraph 3.5.5—

(i)for “Agency” substitute “ appropriate authority ”;

(ii)for “European Reference Laboratory” substitute “ relevant national reference laboratories ”;

(k)in paragraph 3.5.6—

(i)for “Agency's” substitute “appropriate authority's”;

(ii)omit “other EU and”;

(l)in paragraph 3.6.3 for “Agency's” substitute “the appropriate authority's”.

(5) In Annex 2—

(a)in paragraph 2.1—

(i)in the second sentence, for the words from “the Agency's” to the end substitute “ guidance issued by the appropriate authority ”;

(ii)in the third sentence, omit the words from “as defined” to the end;

(b)in paragraph 2.7.2, in the first sentence, for “Agency” substitute “ appropriate authority ”.

Commencement Information

I6Reg. 10 in force at 31.12.2020 on IP completion day (in accordance with 2020 c. 1, Sch. 5 para. 1(1)), see reg. 1(2)(b)

Marginal Citations

M1S.I. 1999/3106, amended by S.I. 2004/994, 2005/2114, 2011/1043, 2018/378.

Back to top

Options/Help

Print Options

Close

Legislation is available in different versions:

Latest Available (revised):The latest available updated version of the legislation incorporating changes made by subsequent legislation and applied by our editorial team. Changes we have not yet applied to the text, can be found in the ‘Changes to Legislation’ area.

Original (As Enacted or Made): The original version of the legislation as it stood when it was enacted or made. No changes have been applied to the text.

Close

See additional information alongside the content

Geographical Extent: Indicates the geographical area that this provision applies to. For further information see ‘Frequently Asked Questions’.

Show Timeline of Changes: See how this legislation has or could change over time. Turning this feature on will show extra navigation options to go to these specific points in time. Return to the latest available version by using the controls above in the What Version box.

Close

Opening Options

Different options to open legislation in order to view more content on screen at once

Close

Explanatory Memorandum

Explanatory Memorandum sets out a brief statement of the purpose of a Statutory Instrument and provides information about its policy objective and policy implications. They aim to make the Statutory Instrument accessible to readers who are not legally qualified and accompany any Statutory Instrument or Draft Statutory Instrument laid before Parliament from June 2004 onwards.

Close

More Resources

Access essential accompanying documents and information for this legislation item from this tab. Dependent on the legislation item being viewed this may include:

  • the original print PDF of the as enacted version that was used for the print copy
  • lists of changes made by and/or affecting this legislation item
  • confers power and blanket amendment details
  • all formats of all associated documents
  • correction slips
  • links to related legislation and further information resources
Close

Timeline of Changes

This timeline shows the different points in time where a change occurred. The dates will coincide with the earliest date on which the change (e.g an insertion, a repeal or a substitution) that was applied came into force. The first date in the timeline will usually be the earliest date when the provision came into force. In some cases the first date is 01/02/1991 (or for Northern Ireland legislation 01/01/2006). This date is our basedate. No versions before this date are available. For further information see the Editorial Practice Guide and Glossary under Help.

Close

More Resources

Use this menu to access essential accompanying documents and information for this legislation item. Dependent on the legislation item being viewed this may include:

  • the original print PDF of the as made version that was used for the print copy
  • correction slips

Click 'View More' or select 'More Resources' tab for additional information including:

  • lists of changes made by and/or affecting this legislation item
  • confers power and blanket amendment details
  • all formats of all associated documents
  • links to related legislation and further information resources